A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
This study has been completed.
First Posted: December 2, 2004
Last Update Posted: February 23, 2017
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 8, 2007|
|Primary Completion Date:||January 8, 2007 (Final data collection date for primary outcome measure)|
Zuckermann A, Wang SS, Ross H, Frigerio M, Eisen HJ, Bara C, Hoefer D, Cotrufo M, Dong G, Junge G, Keogh AM. Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial. J Transplant. 2011;2011:535983. doi: 10.1155/2011/535983. Epub 2011 Sep 13.